SB
IVA

Samsara BioCapital’s Inventiva IVA Stock Holding History

Samsara BioCapital’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.9M Buy
6,314,805
+1,120,000
+22% +$5.38M 1.96% 10
2026
Q1 		$28.8M Hold
5,194,805
– – 2.8% 8
2025
Q4 		$24.2M Buy
+5,194,805
New +$24.1M 2.49% 7

Other funds holding IVA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Samsara BioCapital's IVA Position: Q2 2026 in Review

Samsara BioCapital increased its Inventiva (IVA) stake by 22% in Q2 2026, buying an estimated $5.38M and bringing the position to 6,314,805 shares worth $23.9M. The position accounts for 1.96% of the portfolio, ranked #10.

Samsara BioCapital first reported a position in IVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.8M in Q1 2026. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

  • Samsara BioCapital held 6,314,805 shares of Inventiva worth $23.9M as of Q2 2026.
  • Samsara BioCapital bought 1,120,000 Inventiva shares in Q2 2026, an estimated $5.38M.
  • Inventiva made up 1.96% of Samsara BioCapital's portfolio in Q2 2026, its #10 holding.
  • Samsara BioCapital first reported a position in Inventiva in Q4 2025 and has held it in 3 quarters since.
  • Samsara BioCapital's Inventiva position peaked at $28.8M in Q1 2026.
  • 88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Samsara BioCapital's 13F filing for Q2 2026, filed 14 Aug 2026.